Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. The firm operates its business through four segments. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services to domestic and foreign pharmaceutical and health product manufacturers and other suppliers. The Device Distribution segment distributes medical devices to customers. The Pharmaceutical Retail Business segment owns a network of retail pharmacies that are directly operated or franchised. The Other Business segment is engaged in the manufacture and sale of pharmaceuticals, chemical reagents and laboratory supplies.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2025
06/30/2025
12/31/2024
06/30/2024
12/31/2023
Revenue
575,167
289,124
286,042
289,781
294,726
295,619
Revenue Growth (YoY)
-2%
0%
-3%
-2%
-2%
2%
Cost of Revenue
533,495
267,799
265,696
267,469
272,783
270,378
Gross Profit
41,672
21,325
20,346
22,312
21,943
25,240
Selling, General & Admin
25,021
12,121
12,900
13,244
13,709
13,125
Research & Development
--
--
--
--
--
--
Operating Expenses
24,592
11,933
12,659
12,926
13,558
12,795
Other Non Operating Income (Expenses)
-136
-100
-36
130
-295
336
Pretax Income
14,799
7,589
7,209
6,404
7,596
10,646
Income Tax Expense
3,965
2,092
1,872
1,880
1,697
2,529
Net Income
7,155
3,689
3,465
3,345
3,703
4,949
Net Income Growth
2%
10%
-6%
-32%
-10%
2%
Shares Outstanding (Diluted)
3,120.53
3,120.53
3,120.53
3,120.78
3,120.53
3,124.49
Shares Change (YoY)
0%
0%
0%
0%
0%
0%
EPS (Diluted)
2.29
1.18
1.11
1.07
1.18
1.58
EPS Growth
2%
10%
-6%
-32%
-10%
2%
Free Cash Flow
12,520
47,294
-34,773
51,868
-42,290
59,020
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
7.24%
7.37%
7.11%
7.69%
7.44%
8.53%
Operating Margin
2.96%
3.24%
2.68%
3.23%
2.84%
4.2%
Profit Margin
1.24%
1.27%
1.21%
1.15%
1.25%
1.67%
Free Cash Flow Margin
2.17%
16.35%
-12.15%
17.89%
-14.34%
19.96%
EBITDA
21,368
11,446
9,920
11,794
10,709
14,775
EBITDA Margin
3.71%
3.95%
3.46%
4.06%
3.63%
4.99%
D&A For EBITDA
4,289
2,055
2,233
2,408
2,325
2,330
EBIT
17,079
9,391
7,687
9,386
8,384
12,445
EBIT Margin
2.96%
3.24%
2.68%
3.23%
2.84%
4.2%
Effective Tax Rate
26.79%
27.56%
25.96%
29.35%
22.34%
23.75%
Follow-Up Questions
What are Sinopharm Group Co. Ltd.'s key financial statements?
According to the latest financial statement (Form-10K), Sinopharm Group Co. Ltd. has a total asset of $0, Net loss of $0
What are the key financial ratios for SHTDY?
Sinopharm Group Co. Ltd.'s Current ratio is 0, has a Net margin is 0, sales per share of $0.
How is Sinopharm Group Co. Ltd.'s revenue broken down by segment or geography?
Sinopharm Group Co. Ltd. largest revenue segment is Pharmaceutical Distribution, at a revenue of 460,322,005,211 in the most earnings release.For geography, China is the primary market for Sinopharm Group Co. Ltd., at a revenue of 633,737,461,156.
Is Sinopharm Group Co. Ltd. profitable?
no, according to the latest financial statements, Sinopharm Group Co. Ltd. has a net loss of $0
Does Sinopharm Group Co. Ltd. have any liabilities?
no, Sinopharm Group Co. Ltd. has liability of 0
How many outstanding shares for Sinopharm Group Co. Ltd.?
Sinopharm Group Co. Ltd. has a total outstanding shares of 0